Relling MV - Search Results

1

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

Yang J, Bogni A, Cheng C, Bleibel WK, Cai X, Fan Y, Yang W, Rocha JC, Pei D, Liu W, Dolan ME, Pui CH, Relling MV. Yang J, et al. Among authors: relling mv. Clin Pharmacol Ther. 2008 Dec;84(6):691-7. doi: 10.1038/clpt.2008.86. Epub 2008 May 28. Clin Pharmacol Ther. 2008. PMID: 18509329 Free PMC article. Review.

2

Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Relling MV, Lin JS, Ayers GD, Evans WE. Relling MV, et al. Clin Pharmacol Ther. 1992 Dec;52(6):643-58. doi: 10.1038/clpt.1992.203. Clin Pharmacol Ther. 1992. PMID: 1458773

3

Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.

Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE. Petros WP, et al. Among authors: relling mv. Pharmacotherapy. 1992;12(4):273-7. Pharmacotherapy. 1992. PMID: 1518726

4

Human cytochrome P450 metabolism of teniposide and etoposide.

Relling MV, Evans R, Dass C, Desiderio DM, Nemec J. Relling MV, et al. J Pharmacol Exp Ther. 1992 May;261(2):491-6. J Pharmacol Exp Ther. 1992. PMID: 1578365

5

Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.

Evans WE, Rodman JH, Relling MV, Petros WP, Stewart CF, Pui CH, Rivera GK. Evans WE, et al. Among authors: relling mv. J Pharmacol Exp Ther. 1992 Jan;260(1):71-7. J Pharmacol Exp Ther. 1992. PMID: 1731053

6

Increased teniposide clearance with concomitant anticonvulsant therapy.

Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH. Baker DK, et al. Among authors: relling mv. J Clin Oncol. 1992 Feb;10(2):311-5. doi: 10.1200/JCO.1992.10.2.311. J Clin Oncol. 1992. PMID: 1732431

7

Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia.

Evans WE, Rodman J, Relling MV, Crom WR, Rivera GK, Crist WM, Pui CH. Evans WE, et al. Among authors: relling mv. Semin Hematol. 1991 Jul;28(3 Suppl 4):15-21. Semin Hematol. 1991. PMID: 1780747 Review. No abstract available.

8

Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.

Crom WR, Relling MV, Christensen ML, Rivera GK, Evans WE. Crom WR, et al. Among authors: relling mv. Clin Pharmacol Ther. 1991 Aug;50(2):132-40. doi: 10.1038/clpt.1991.117. Clin Pharmacol Ther. 1991. PMID: 1868674

9

Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.

Kalwinsky DK, Raimondi SC, Bunin NJ, Fairclough D, Pui CH, Relling MV, Ribeiro R, Rivera GK. Kalwinsky DK, et al. Among authors: relling mv. Am J Med Genet Suppl. 1990;7:267-71. doi: 10.1002/ajmg.1320370753. Am J Med Genet Suppl. 1990. PMID: 2149960

10

Anticancer therapy as a pediatric pharmacodynamic paradigm.

Evans WE, Relling MV, Rodman JH, Crom WR. Evans WE, et al. Among authors: relling mv. Dev Pharmacol Ther. 1989;13(2-4):85-95. doi: 10.1159/000457589. Dev Pharmacol Ther. 1989. PMID: 2693007 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters